Who has invested in Biosyngen?

Science City (Guangzhou) Investment Group Co., Ltd. are named among the investors backing Biosyngen.

Biosyngen Funding: $86M Raised, Venture

Biosyngen funding overview

Biosyngen is based in Singapore, Singapore. Biosyngen has raised $86M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Venture - Series Unknown announced in October 2021. The round record for Biosyngen runs through 2021; nothing later has been disclosed. Investors on record include Science City (Guangzhou) Investment Group Co., Ltd..

Biosyngen at a glance

Total raised: $86M
Latest round: Venture - Series Unknown
Latest round date: October 2021
Headquarters: Singapore, Singapore
Notable investors: Science City (Guangzhou) Investment Group Co., Ltd.

Frequently asked about Biosyngen funding

How much has Biosyngen raised?: Biosyngen has raised $86M in total disclosed funding across the rounds on record.
Who has invested in Biosyngen?: Science City (Guangzhou) Investment Group Co., Ltd. are named among the investors backing Biosyngen.
What was the latest Biosyngen funding round?: The most recent disclosed round is a Venture - Series Unknown, announced in October 2021.
Where is Biosyngen based?: Biosyngen is based in Singapore, Singapore.
When did Biosyngen last raise?: The last disclosed Biosyngen round closed in October 2021 at Venture - Series Unknown.

Biosyngen totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Singapore below to benchmark round size and investor mix.

Biosyngen Funding: $86M Raised, Venture - Series Unknown

Biosyngen funding overview

Biosyngen at a glance

Frequently asked about Biosyngen funding

Companies related to Biosyngen (18)

Browse related funding lists (4)